Prescribing Cascades with Recommendations to Prevent or Reverse Them: A Systematic Review

Overview

Journal Drugs Aging

Specialties Geriatrics
Pharmacology

Date 2023 Oct 20

PMID 37863868

Authors

Oriane Adrien

Atiya K Mohammad

Jacqueline G Hugtenburg

Lisa M McCarthy

Simone Priester-Vink

Robbert Visscher

Patricia M L A Van den Bemt

Petra Denig

Fatma Karapinar-Carkit

Affiliations

Soon will be listed here.

Abstract

Background: To reduce prescribing cascades occurring in clinical practice, healthcare providers require information on the prescribing cascades they can recognize and prevent.

Objective: This systematic review aims to provide an overview of prescribing cascades, including dose-dependency information and recommendations that healthcare providers can use to prevent or reverse them.

Methods: The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) was followed. Relevant literature was identified through searches in OVID MEDLINE, OVID Embase, OVID CINAHL, and Cochrane. Additionally, Web of Science and Scopus were consulted to analyze reference lists and citations. Publications in English were included if they analyzed the occurrence of prescribing cascades. Prescribing cascades were included if at least one study demonstrated a significant association and were excluded when the adverse drug reaction could not be confirmed in the Summary of Product Characteristics. Two reviewers independently extracted and grouped similar prescribing cascades. Descriptive summaries were provided regarding dose-dependency analyses and recommendations to prevent or reverse these prescribing cascades.

Results: A total of 95 publications were included, resulting in 115 prescribing cascades with confirmed adverse drug reactions for which at least one significant association was found. For 52 of these prescribing cascades, information regarding dose dependency or recommendations to prevent or reverse prescribing cascades was found. Dose dependency was analyzed and confirmed for 12 prescribing cascades. For example, antipsychotics that may cause extrapyramidal syndrome followed by anti-parkinson drugs. Recommendations focused on dosage lowering, discontinuing medication, and medication switching. Explicit recommendations regarding alternative options were given for three prescribing cascades. One example was switching to ondansetron or granisetron when extrapyramidal syndrome is experienced using metoclopramide.

Conclusions: In total, 115 prescribing cascades were identified and an overview of 52 of them was generated for which recommendations to prevent or reverse them were provided. Nonetheless, information regarding alternative options for managing prescribing cascades was scarce.

Citing Articles

Pharmacy-led interventions to reverse and prevent prescribing cascades in primary care: a proof-of-concept study.

Mohammad A, Hugtenburg J, Ceylan Y, Kooij M, Knies S, Van den Bemt P Int J Clin Pharm. 2025; .

PMID: 39954224 DOI: 10.1007/s11096-025-01873-8.

Exploring Sex, Gender, and Gender-Related Sociocultural Factors in Clinical Decision-Making for Older Adults Using a Prescribing Cascade Vignette: A Transnational Qualitative Study.

Kthupi A, Rochon P, Santini S, Paoletti L, Mason R, McCarthy L Drugs Aging. 2024; 41(12):977-988.

PMID: 39602002 DOI: 10.1007/s40266-024-01158-1.

Deprescribing oral antidiabetics in elderly patients: Do electronic leaflets across the world address it?.

Bunnel K, Carvalho Jr S, Pereira M, Couto R, Baldoni A Explor Res Clin Soc Pharm. 2024; 16:100537.

PMID: 39584023 PMC: 11584748. DOI: 10.1016/j.rcsop.2024.100537.

Medication adherence in geriatric patients attending medical outpatient department.

Odubanjo O, Tipping B, Greenstein L S Afr Fam Pract (2004). 2024; 66(1):e1-e8.

PMID: 39494658 PMC: 11538091. DOI: 10.4102/safp.v66i1.6011.

Identifying and quantifying potentially problematic prescribing cascades in clinical practice: A mixed-methods study.

Mohammad A, Hugtenburg J, Vanhommerig J, Van den Bemt P, Denig P, Karapinar-Carkit F J Am Geriatr Soc. 2024; 72(12):3681-3694.

PMID: 39305008 PMC: 11637293. DOI: 10.1111/jgs.19191.

References

Rochon P, Gurwitz J . Drug therapy. Lancet. 1995; 346(8966):32-6. DOI: 10.1016/s0140-6736(95)92656-9. View

Farrell B, Galley E, Jeffs L, Howell P, McCarthy L . "Kind of blurry": Deciphering clues to prevent, investigate and manage prescribing cascades. PLoS One. 2022; 17(8):e0272418. PMC: 9432713. DOI: 10.1371/journal.pone.0272418. View

Brath H, Mehta N, Savage R, Gill S, Wu W, Bronskill S . What Is Known About Preventing, Detecting, and Reversing Prescribing Cascades: A Scoping Review. J Am Geriatr Soc. 2018; 66(11):2079-2085. DOI: 10.1111/jgs.15543. View

McCarthy L, Visentin J, Rochon P . Assessing the Scope and Appropriateness of Prescribing Cascades. J Am Geriatr Soc. 2019; 67(5):1023-1026. DOI: 10.1111/jgs.15800. View

Morris E, Hollmann J, Hofer A, Bhagwandass H, Oueini R, Adkins L . Evaluating the use of prescription sequence symmetry analysis as a pharmacovigilance tool: A scoping review. Res Social Adm Pharm. 2021; 18(7):3079-3093. DOI: 10.1016/j.sapharm.2021.08.003. View

Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71. PMC: 8005924. DOI: 10.1136/bmj.n71. View

Monane M, Bohn R, Gurwitz J, Glynn R, Choodnovskiy I, Avorn J . Topical glaucoma medications and cardiovascular risk in the elderly. Clin Pharmacol Ther. 1994; 55(1):76-83. DOI: 10.1038/clpt.1994.13. View

Avorn J, Gurwitz J, Bohn R, Mogun H, Monane M, Walker A . Increased incidence of levodopa therapy following metoclopramide use. JAMA. 1995; 274(22):1780-2. View

Huh Y, Kim D, Choi M, Park J, Kwon D, Jung J . Metoclopramide and Levosulpiride Use and Subsequent Levodopa Prescription in the Korean Elderly: The Prescribing Cascade. J Clin Med. 2019; 8(9). PMC: 6780178. DOI: 10.3390/jcm8091496. View

10.

Janetzki J, Sykes M, Ward M, Pratt N . Proton pump inhibitors may contribute to progression or development of chronic obstructive pulmonary disease-A sequence symmetry analysis approach. J Clin Pharm Ther. 2021; 46(6):1687-1694. DOI: 10.1111/jcpt.13520. View

11.

Hashimoto M, Hashimoto K, Ando F, Kimura Y, Nagase K, Arai K . Prescription rate of medications potentially contributing to lower urinary tract symptoms and detection of adverse reactions by prescription sequence symmetry analysis. J Pharm Health Care Sci. 2016; 1:7. PMC: 4728807. DOI: 10.1186/s40780-014-0004-1. View

12.

Caughey G, Roughead E, Pratt N, Shakib S, Vitry A, Gilbert A . Increased risk of hip fracture in the elderly associated with prochlorperazine: is a prescribing cascade contributing?. Pharmacoepidemiol Drug Saf. 2010; 19(9):977-82. DOI: 10.1002/pds.2009. View

13.

Gurwitz J, Kalish S, Bohn R, Glynn R, Monane M, Mogun H . Thiazide diuretics and the initiation of anti-gout therapy. J Clin Epidemiol. 1997; 50(8):953-9. DOI: 10.1016/s0895-4356(97)00101-7. View

14.

Nishtala P, Chyou T . Exploring New Zealand prescription data using sequence symmetry analyses for predicting adverse drug reactions. J Clin Pharm Ther. 2016; 42(2):189-194. DOI: 10.1111/jcpt.12491. View

15.

Bouvy M, Heerdink E, Hoes A, Leufkens H . Amiodarone-induced thyroid dysfunction associated with cumulative dose. Pharmacoepidemiol Drug Saf. 2002; 11(7):601-6. DOI: 10.1002/pds.735. View

16.

Pratt N, Chan E, Choi N, Kimura M, Kimura T, Kubota K . Prescription sequence symmetry analysis: assessing risk, temporality, and consistency for adverse drug reactions across datasets in five countries. Pharmacoepidemiol Drug Saf. 2015; 24(8):858-64. PMC: 4690514. DOI: 10.1002/pds.3780. View

17.

Yokoyama S, Tanaka Y, Hosomi K, Takada M . Polypharmacy Is Associated With Amiodarone-Induced Hypothyroidism. Int J Med Sci. 2021; 18(15):3574-3580. PMC: 8436091. DOI: 10.7150/ijms.61412. View

18.

Garrison S, Dormuth C, Morrow R, Carney G, Khan K . Nocturnal leg cramps and prescription use that precedes them: a sequence symmetry analysis. Arch Intern Med. 2011; 172(2):120-6. DOI: 10.1001/archinternmed.2011.1029. View

19.

Savage R, Visentin J, Bronskill S, Wang X, Gruneir A, Giannakeas V . Evaluation of a Common Prescribing Cascade of Calcium Channel Blockers and Diuretics in Older Adults With Hypertension. JAMA Intern Med. 2020; 180(5):643-651. PMC: 7042805. DOI: 10.1001/jamainternmed.2019.7087. View

20.

Singh S, Cocoros N, Haynes K, Nair V, Harkins T, Rochon P . Identifying prescribing cascades in Alzheimer's disease and related dementias: The calcium channel blocker-diuretic prescribing cascade. Pharmacoepidemiol Drug Saf. 2021; 30(8):1066-1073. DOI: 10.1002/pds.5230. View